- Home
- » Tags
- » Methoxsalen
Top View
- 2016 12 08 Aldulaimi Fruits Final
- Proquest Dissertations
- Naturally Occurring Food Toxins
- Methoxsalen Plus Ultraviolet a Radiation
- Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
- UVADEX® (Methoxsalen) STERILE SOLUTION, 20 Mcg/Ml
- GIANT HOGWEED Christopher Holstege, MD
- Coumarins As Potential Supportive Medication for the Treatment Of
- Architectures of US FDA Approved Pharmaceuticals Containing
- Psoriasis Treatment: Traditional Therapy M Lebwohl, P T Ting, J Y M Koo
- ATC-Index Mit DDD-Angaben Für Deutschland Im Jahre 2019
- Methoxsalen and Bergapten Prevent Diabetes-Induced Osteoporosis by the Suppression of Osteoclastogenic Gene Expression in Mice
- OXSORALEN® LOTION 1% (Methoxsalen USP, 1%)
- Therapeutic and Toxic Blood Concentrations of More Than 1100 Drugs and Other Xenobiotics
- In Vivo Modulation of the Behavioral Effects of Nicotine by the Coumarins Xanthotoxin, Bergapten, and Umbelliferone
- ICD-10-CM TABLE of DRUGS and CHEMICALS 2020
- Guidelines for ATC Classification and DDD Assignment 2021
- Coal Tar Solution: Summary Report
- THERAKOS CELLEX Photopheresis System
- The Adverse Effects of the Methoxsalen and Ultraviolent a Radiation on Spermatogenesis in Mice
- (EDL) and a Licensed Drugs List (LDL) for Afghanistan
- Coumarin-Based Profluorescent and Fluorescent Substrates For
- 8-Methoxypsoralen
- QSTR Approaches Regarding Their Genotoxicity
- Hazardous Chemicals Handbook
- Nagasaki University's Academic Output SITE
- Title 16. Crimes and Offenses Chapter 13
- ICD-10-CM Table of Drugs 2019
- UVADEX (Methoxsalen) STERILE SOLUTION, 20 Mcg/Ml Rx ONLY
- International Classification of Procedures in Medicine
- (12) United States Patent (10) Patent No.: US 8,057,785 B2 Decola Et Al
- WO 2012/170676 Al 13 December 2012 (13.12.2012) P O P C T
- German Evidence-Based Guidelines for the Treatment of Psoriasis Vulgaris (Short Version)
- Resolution Ap (2000) 1
- Basic Considerations of the Psoralens
- Methoxsalen with Ultraviolet a Therapy Which It Has Been Applied Receives Excess Exposure to UVA
- Establishment of Framework for Classification/Categorisation and Labelling of Medicinal Drugs and Driving
- Modification of Ultraviolet Carcinogenesis by Photoactive Agents*
- Non-FDA Approved Medication and Product List